Effect of darvyadi eye drops in Kaphaja Abhishyanda (acute mucopurulent conjunctivitis)

Phase 2/3

Not yet recruiting

• Conditions: Mucopurulent conjunctivitis. Ayurveda Condition: KAPABISHYANDAH,

• Registration Number: CTRI/2025/03/083322
• Lead Sponsor: Parul Institute of Ayurved

Brief Summary

1.Acute mucopurulent conjunctivitis is often under diagnosed and consequently under treated.

2. Acute mucopurulent conjunctivitis is the most common prevalence is India rate 17.23–22.52 %.

3. Cases of *Kaphaja**Abhishyanda**(*Acute mucopurulent *Conjunctivitis)*is frequently seen in OPD of *Shalakya**tantra* on a routine basis.

4. There is a need to develop a therapy that is without side effect and less expensive.

5. We have tried to prepare *Darvyadi* eye Drops in order to get over these challenges and make *ayurvedic* procedures more patients friendly.

6.Many patients are unable to visit the hospital for a fairly straightforward procedure due to a fast- paced lifestyle, hectic working hours, as well as other unavoidable factors.

7.The purpose of the study is to compare the *Darvyadi*eye Drops with ciprofloxacin eye Drops (0.3%), in *Kaphaja Abhishyanda* under the identical circumstances

Detailed Description

Not available

Study Timeline

• Last Update Posted: 2025-03-25
• Study Start: 2025-10-04

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: Not specified
• Target Recruitment: 60

Inclusion Criteria

1 Patients presenting with the signs and symptoms of Kaphaja Abhishyanda will be selected 2 Patients irrespective of Gender religion and socio-economic status will be included in study.

Exclusion Criteria

1 Patients not willing to participate in the study 2 Severe cases of conjunctivitis with complications like corneal ulcers trachoma dacryocystitis etc 3 Eye associated with any other inflammatory and infective ocular conditions 4 Patients with known case of Hypertension Diabetes mellitus and any major systemic illness.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
1.Evaluation of efficacy of darvyadi eye drops and Ciprofloxacin eye drops	Baseline DAY 1 | DAY 8 | DAY 15
4.Relief from discomfort and itching sensation	Baseline DAY 1 | DAY 8 | DAY 15
3.Reduction in redness and discharge	Baseline DAY 1 | DAY 8 | DAY 15
5.Vision restoration	Baseline DAY 1 | DAY 8 | DAY 15
2.Comparison of efficacy of darvyadi eye drops and ciporifloxacin eyedrops in the management ofkaphaj abhiushyanda with special reference to acute mucopurulent conjunctivitis	Baseline DAY 1 | DAY 8 | DAY 15

Secondary Outcome Measures

Name	Time	Method
Relief from symptoms of acute mucopurulent conjunctivitis	15 days

Trial Locations

Locations (1)

Parul Ayurved Hospital; 🇮🇳 Vadodara, GUJARAT, India

Parul Ayurved Hospital

🇮🇳Vadodara, GUJARAT, India

Dr Ravi Shanker Pareek

Principal investigator

09636904383

ravipareek132@gmail.com